Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
Quanscient | $5,667,883 | (Nov 5, 2024)
NeuroFlow
United States
- Philadelphia, PA
- 17/10/2022
- Series B
- $25,000,000
There is a health crisis in America. In every community, 1 in 4 people live with mental health disorders and the demand for behavioral health services has been amplified in the wake of COVID-19. Social isolation, economic downturns, and tense conditions have amplified the effects of depression, anxiety, and substance use disorder.
NeuroFlow is a digital health company combining workflow automation, patient engagement solutions and services, and applied AI to promote behavioral health integration in all care settings. NeuroFlow’s suite of services and HIPAA-compliant, cloud-based tools simplify remote patient monitoring, improve risk stratification, and facilitate collaborative care.
With NeuroFlow, health care organizations can finally bridge the gap between mental and physical health in order to improve outcomes and reduce the cost of care.
- Industry Wellness and Fitness Services
- Website https://www.neuroflow.com/
- LinkedIn https://www.linkedin.com/company/neuroflow/
Related People
Adam PardesCo Founder
United States -
Philadelphia, Pennsylvania,
Adam Pardes is the co-founder and COO at NeuroFlow, a digital health technology and analytics company promoting behavioral health access and engagement in all care settings. Prior to NeuroFlow, Adam published nearly a dozen peer-reviewed manuscripts while pursuing a PhD in Bioengineering and simultaneously consulting for high-growth SaaS startups.
In six years at NeuroFlow, he’s built from scratch a scalable operational infrastructure, recruiting and onboarding 100+ employees with world-class talent. He’s helped the company raise over $57 million through five investment rounds, support more than 15 million users through the platform, and publish multiple peer-reviewed studies demonstrating the positive impact of NeuroFlow on clinical practice and patient outcomes.
Adam has been invited to speak on numerous panels, seminars, and keynote sessions as an expert on mental health, healthcare IT, and innovation at prestigious institutions including MIT and University of Pennsylvania. He also serves as a consultant, advisor, and board member for early-stage ventures to support the next generation of innovative entrepreneurs.
Miros | $6,535,520 | (Nov 5, 2024)
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Inquis Medical, Inc. | $40,000,000 | (Nov 5, 2024)
CrossBridge Bio | $10,000,000 | (Nov 5, 2024)